Antibiotics are medicines that fight bacterial infections in people and animals. They work by killing the bacteria or by making it hard for the bacteria to grow and multiply. The global Antibiotics market is mainly driven by the development of novel methods for new antibiotics for treating bacterial infections and a large number of clinical trials.
Furthermore, the rising incidence of infectious diseases such as HIV/AIDS, pneumonia, malaria, and tuberculosis, and the current gap in the demand and supply of antibiotics are some important factors significantly boosting the growth of the global Antibiotics market. Additionally, growing investments in research and development by biotech companies are projected to enlarge the growth of the global Antibiotics market.
On the other hand, the development of antibiotic resistance and increase in drug approval costs are anticipated to hamper the growth of the market. Besides this, the discovery of advanced prospect molecules and the introduction of novel combination therapies to treat antibiotic-resistant microbial infections are anticipated to create lucrative opportunities for market players during the forecast period.
Covid-19 Impact on Antibiotics Market
In addition, the current Antibiotics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Antibiotics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Antibiotics Market Segment Overview
Based on Drug Class, the Beta-Lactams is the fastest-growing segment in the global Antibiotics market. Growth of the beta-lactams segment can be attributed to rapidly increasing antibacterial resistance, the need for a new broad spectrum of agents, and the need to control infection in health care settings. According to Distribution Channel, Online Pharmacies are the largest segment in the market. The growth of the online pharmacies segment can be mainly attributed to the focus of e-commerce companies on the pharmaceutical sector to deliver medication to customers at the doorstep and ease of buying medication online.
Antibiotics Market, By Drug Class
- Aminoglycosides
- Beta-Lactams
- Penicillin
- Carbapenems
- Cephalosporin
- Macrolides
- Phenicols
- Quinolones/Fluoroquinolones
- Tetracycline
- Sulfonamides
- Others
· Oral
· Topical
· Sublingual
· Inhalation
· Intravenous
Antibiotics Market, By Distribution Channel
· Hospital Pharmacies
· Retail Pharmacies
· Online Pharmacies
Antibiotics Regional Overview
Region-wise, Asia Pacific commanded a major share, in terms of revenue of the global Antibiotics market. This is due to the increasing prevalence of various infectious diseases, favorable regulatory reforms, growing population & unhygienic conditions giving rise to antibiotic resistance bacteria, and significant demand for generic medicines. Likewise, North America and Europe are key regions for the Antibiotics market. Important factors such as well-developed healthcare infrastructure, the rising incidence of infectious diseases, and growing healthcare expenditure by the government are largely contributes to the development of the market in these regions.
Antibiotics Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Antibiotics Market, Key Players
· AstraZeneca plc
· Bristol-Myers Squibb Co.
· Bayer HealthCare AG
· The Menarini Group
· GlaxoSmithKline plc
· Eli Lilly and Company
· Johnson & Johnson
· Merck & Co., Inc.
· Novartis AG
· Sanofi
· Teva Pharmaceutical Industries Ltd.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Antibiotics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Drug Class
- 5.2.1. Aminoglycosides
- 5.2.2. Beta-Lactams
- 5.2.2.1. Penicillin
- 5.2.2.2. Carbapenems
- 5.2.2.3. Cephalosporin
- 5.2.3. Macrolides
- 5.2.4. Phenicols
- 5.2.5. Quinolones/Fluoroquinolones
- 5.2.6. Tetracycline
- 5.2.7. Sulfonamides
- 5.2.8. Others
- 5.3. Market Analysis, Insights and Forecast – By Route Of Administration
- 5.3.1. Oral
- 5.3.2. Topical
- 5.3.3. Sublingual
- 5.3.4. Inhalation
- 5.3.5. Intravenous
- 5.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.4.1. Hospital Pharmacies
- 5.4.2. Retail Pharmacies
- 5.4.3. Online Pharmacies
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Antibiotics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Drug Class
- 6.2.1. Aminoglycosides
- 6.2.2. Beta-Lactams
- 6.2.2.1. Penicillin
- 6.2.2.2. Carbapenems
- 6.2.2.3. Cephalosporin
- 6.2.3. Macrolides
- 6.2.4. Phenicols
- 6.2.5. Quinolones/Fluoroquinolones
- 6.2.6. Tetracycline
- 6.2.7. Sulfonamides
- 6.2.8. Others
- 6.3. Market Analysis, Insights and Forecast – By Route Of Administration
- 6.3.1. Oral
- 6.3.2. Topical
- 6.3.3. Sublingual
- 6.3.4. Inhalation
- 6.3.5. Intravenous
- 6.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.4.1. Hospital Pharmacies
- 6.4.2. Retail Pharmacies
- 6.4.3. Online Pharmacies
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Antibiotics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Drug Class
- 7.2.1. Aminoglycosides
- 7.2.2. Beta-Lactams
- 7.2.2.1. Penicillin
- 7.2.2.2. Carbapenems
- 7.2.2.3. Cephalosporin
- 7.2.3. Macrolides
- 7.2.4. Phenicols
- 7.2.5. Quinolones/Fluoroquinolones
- 7.2.6. Tetracycline
- 7.2.7. Sulfonamides
- 7.2.8. Others
- 7.3. Market Analysis, Insights and Forecast – By Route Of Administration
- 7.3.1. Oral
- 7.3.2. Topical
- 7.3.3. Sublingual
- 7.3.4. Inhalation
- 7.3.5. Intravenous
- 7.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.4.1. Hospital Pharmacies
- 7.4.2. Retail Pharmacies
- 7.4.3. Online Pharmacies
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Antibiotics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Drug Class
- 8.2.1. Aminoglycosides
- 8.2.2. Beta-Lactams
- 8.2.2.1. Penicillin
- 8.2.2.2. Carbapenems
- 8.2.2.3. Cephalosporin
- 8.2.3. Macrolides
- 8.2.4. Phenicols
- 8.2.5. Quinolones/Fluoroquinolones
- 8.2.6. Tetracycline
- 8.2.7. Sulfonamides
- 8.2.8. Others
- 8.3. Market Analysis, Insights and Forecast – By Route Of Administration
- 8.3.1. Oral
- 8.3.2. Topical
- 8.3.3. Sublingual
- 8.3.4. Inhalation
- 8.3.5. Intravenous
- 8.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.4.1. Hospital Pharmacies
- 8.4.2. Retail Pharmacies
- 8.4.3. Online Pharmacies
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Antibiotics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Drug Class
- 9.2.1. Aminoglycosides
- 9.2.2. Beta-Lactams
- 9.2.2.1. Penicillin
- 9.2.2.2. Carbapenems
- 9.2.2.3. Cephalosporin
- 9.2.3. Macrolides
- 9.2.4. Phenicols
- 9.2.5. Quinolones/Fluoroquinolones
- 9.2.6. Tetracycline
- 9.2.7. Sulfonamides
- 9.2.8. Others
- 9.3. Market Analysis, Insights and Forecast – By Route Of Administration
- 9.3.1. Oral
- 9.3.2. Topical
- 9.3.3. Sublingual
- 9.3.4. Inhalation
- 9.3.5. Intravenous
- 9.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.4.1. Hospital Pharmacies
- 9.4.2. Retail Pharmacies
- 9.4.3. Online Pharmacies
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. AstraZeneca plc
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Bristol-Myers Squibb Co.
- 10.6. Bayer HealthCare AG
- 10.7. The Menarini Group
- 10.8. GlaxoSmithKline plc
- 10.9. Eli Lilly and Company
- 10.10. Johnson & Johnson
- 10.11. Merck & Co., Inc.
- 10.12. Novartis AG
- 10.13. Sanofi
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
